2025-01-01 2025-12-31 2025-12-31 false 14352444 Real Estate Meta Ltd 62012Business and domestic software development iso4217:GBP xbrli:pure 143524442025-01-01 143524442025-12-31 143524442025-01-01 2025-12-31 14352444bus:SmallEntities2025-01-01 2025-12-31 14352444bus:AuditExempt-NoAccountantsReport2025-01-01 2025-12-31 14352444bus:FullAccounts2025-01-01 2025-12-31 14352444core:WithinOneYear2025-12-31 14352444core:AfterOneYear2025-12-31 14352444core:WithinOneYear2025-01-01 2025-12-31 14352444core:AfterOneYear2025-01-01 2025-12-31 14352444core:CurrentFinancialInstruments2025-12-31 14352444core:Non-currentFinancialInstruments2025-12-31 14352444core:CurrentFinancialInstruments2025-01-01 2025-12-31 14352444core:Non-currentFinancialInstruments2025-01-01 2025-12-31 14352444core:LandBuildings2025-01-01 2025-12-31 14352444core:FurnitureFittings2025-01-01 2025-12-31 14352444core:OfficeEquipment2025-01-01 2025-12-31 14352444core:Vehicles2025-01-01 2025-12-31 14352444core:PlantMachinery2025-01-01 2025-12-31 14352444core:OtherPropertyPlantEquipment2025-01-01 2025-12-31 14352444core:LandBuildings2025-12-31 14352444core:PlantMachinery2025-12-31 14352444core:Vehicles2025-12-31 14352444core:FurnitureFittings2025-12-31 14352444core:OfficeEquipment2025-12-31 14352444core:OtherPropertyPlantEquipment2025-12-31 14352444core:Right-of-useAssets2025-01-01 2025-12-31 14352444core:Right-of-useAssets2025-12-31 14352444core:Goodwill2025-01-01 2025-12-31 14352444core:PatentsTrademarksLicencesConcessionsSimilar2025-01-01 2025-12-31 14352444core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-01-01 2025-12-31 14352444core:OtherResidualIntangibleAssets2025-01-01 2025-12-31 14352444core:Goodwill2025-12-31 14352444core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-12-31 14352444core:PatentsTrademarksLicencesConcessionsSimilar2025-12-31 14352444core:OtherResidualIntangibleAssets2025-12-31 14352444dpl:CostSales2025-01-01 2025-12-31 14352444dpl:AdministrativeExpenses2025-01-01 2025-12-31 14352444dpl:DistributionCosts2025-01-01 2025-12-3114352444core:ShareCapital2025-12-31 14352444core:SharePremium2025-12-31 14352444core:RevaluationReserve2025-12-31 14352444core:OtherReservesSubtotal2025-12-31 14352444core:ShareCapitalPreferenceShares2025-12-31 14352444core:CapitalRedemptionReserve2025-12-31 14352444core:OtherCapitalReserve2025-12-31 14352444core:RetainedEarningsAccumulatedLosses2025-12-3114352444core:ShareCapital2025-01-01 2025-12-31 14352444core:SharePremium2025-01-01 2025-12-31 14352444core:RevaluationReserve2025-01-01 2025-12-31 14352444core:OtherReservesSubtotal2025-01-01 2025-12-31 14352444core:RetainedEarningsAccumulatedLosses2025-01-01 2025-12-311435244412025-01-01 2025-12-31 1435244422025-01-01 2025-12-3114352444core:ShareCapital12025-01-01 2025-12-31 14352444core:ShareCapital22025-01-01 2025-12-3114352444core:SharePremium12025-01-01 2025-12-31 14352444core:SharePremium22025-01-01 2025-12-3114352444core:RevaluationReserve12025-01-01 2025-12-31 14352444core:RevaluationReserve22025-01-01 2025-12-3114352444core:RetainedEarningsAccumulatedLosses12025-01-01 2025-12-31 14352444core:RetainedEarningsAccumulatedLosses22025-01-01 2025-12-311435244412025-01-01 2025-12-3114352444core:Non-currentFinancialInstrumentscore:CostValuation2025-01-01 14352444core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-31 14352444core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-3114352444core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-31 14352444core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2025-12-31 14352444core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3114352444core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-01-01 14352444core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-31 14352444core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-31 14352444core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-31 14352444core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2025-12-31 14352444core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-31 14352444core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-12-3114352444core:Non-currentFinancialInstruments2025-12-31 14352444core:Non-currentFinancialInstruments2024-12-31143524442024-01-01 143524442024-12-31 143524442024-01-01 2024-12-31 14352444core:WithinOneYear2024-12-31 14352444core:AfterOneYear2024-12-31 14352444core:CurrentFinancialInstruments2024-12-31 14352444core:Non-currentFinancialInstruments2024-12-31 14352444core:LandBuildings2024-12-31 14352444core:PlantMachinery2024-12-31 14352444core:Vehicles2024-12-31 14352444core:FurnitureFittings2024-12-31 14352444core:OfficeEquipment2024-12-31 14352444core:OtherPropertyPlantEquipment2024-12-31 14352444core:Right-of-useAssets2024-12-31 14352444core:Goodwill2024-12-31 14352444core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-12-31 14352444core:PatentsTrademarksLicencesConcessionsSimilar2024-12-31 14352444core:OtherResidualIntangibleAssets2024-12-31 14352444dpl:AdministrativeExpenses2024-01-01 2024-12-3114352444core:ShareCapital2024-12-31 14352444core:SharePremium2024-12-31 14352444core:RevaluationReserve2024-12-31 14352444core:OtherReservesSubtotal2024-12-31 14352444core:ShareCapitalPreferenceShares2024-12-31 14352444core:CapitalRedemptionReserve2024-12-31 14352444core:OtherCapitalReserve2024-12-31 14352444core:RetainedEarningsAccumulatedLosses2024-12-3114352444core:RetainedEarningsAccumulatedLosses2024-01-01 14352444core:ShareCapital2024-01-01 14352444core:SharePremium2024-01-01 14352444core:RevaluationReserve2024-01-01 14352444core:ShareCapital2024-01-01 2024-12-31 14352444core:SharePremium2024-01-01 2024-12-31 14352444core:RevaluationReserve2024-01-01 2024-12-31 14352444core:OtherReservesSubtotal2024-01-01 2024-12-31 14352444core:RetainedEarningsAccumulatedLosses2024-01-01 2024-12-311435244412024-01-01 2024-12-31 1435244422024-01-01 2024-12-3114352444core:ShareCapital12024-01-01 2024-12-31 14352444core:ShareCapital22024-01-01 2024-12-3114352444core:SharePremium12024-01-01 2024-12-31 14352444core:SharePremium22024-01-01 2024-12-3114352444core:RevaluationReserve12024-01-01 2024-12-31 14352444core:RevaluationReserve22024-01-01 2024-12-3114352444core:RetainedEarningsAccumulatedLosses12024-01-01 2024-12-31 14352444core:RetainedEarningsAccumulatedLosses22024-01-01 2024-12-3114352444bus:Director12025-01-01 2025-12-3114352444bus:Director22025-01-01 2025-12-3114352444bus:Director32025-01-01 2025-12-3114352444bus:PrivateLimitedCompanyLtd2025-01-01 2025-12-31
Real Estate Meta Ltd
Unaudited Financial Statements
for the year ended 31 December 2025
Company registration number 14352444
(England and Wales)

Company Information

For the year ended 31 December 2025
Directors Rasheed, Zahid
Levett, Peter Aston
Berger, Wayne Darren

Registered office 3rd Floor Waverley House
7-12 Noel Street
London
W1F 8GQ

Registered number 14352444

Accountant Ecovis Wingrave Yeats UK Limited
Waverley House, 7-12 Noel Street
London
England
W1F 8GQ

Balance Sheet

As at 31 December 2025
Notes
2025
2024
£
£
£
£
Current assets
Debtors
4
-
82,592
Cash at bank and in hand
90,714
17,938
90,714
100,530
Creditors
Amounts falling due within one year
5
(10,204)
(5,458)
(10,204)
(5,458)
Net current assets (liabilities)
80,510
95,072
Total assets less current liabilities
80,510
95,072
Net assets (liabilities)
80,510
95,072
Capital and reserves
Called up share capital
6
84,266
79,066
Share premium account
312,414
264,989
Profit and loss account
(316,170)
(248,983)
Total equity
80,510
95,072

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 15 September 2026 and are signed on its behalf by:

Levett, Peter Aston
Levett, Peter Aston
Director

Company registration number 14352444

Notes to the Financial Statements

For the year ended 31 December 2025

1. Statutory information

The company is a private company limited by shares and registered in England and Wales.

The company's registered number and registered office address can be found on the Company Information page.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

2.2. Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.

2.3. Foreign currency translation

Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

2.4. Interest income

Interest income is recognised using the effective interest rate method.

2.5. Trade and other debtors

Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

2.6. Trade and other creditors

Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

2.7. Share capital

Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.

2.8. Functional Currency

The financial statements are presented in sterling and this is the functional currency of the company.

3. Employees

The average number of employees during the year was 0 (2024: 0).

4. Debtors

2025
2024
£
£
Other debtors
-
82,592
Total due within one year
-
82,592
Total due after one year
-
-
Total
-
82,592

5. Creditors due within one year

2025
2024
£
£
Trade creditors
4,894
510
Accruals and deferred income
5,310
4,948
Total
10,204
5,458

6. Share capital

2025
2024
£
£
Allotted, called up and fully paid
Ordinary shares
84,266
79,066
Total
84,266
79,066


Upon incorporation 1,000 Ordinary £0.01 shares were issued. On 19 April 2023, a further 5,000,000 Ordinary £0.01 shares were issued. On 2 July 2024, a further 2,905,581 Ordinary £0.01 shares were issued at a price of £0.1012 per share, resulting in a share premium of £264,989. On 30 December 2025, the company issued 520,007 Ordinary £0.01 shares at a price of £0.1012 per share, giving rise to a share premium of £47,425.

7. Related party transactions

At 1 January 2025, the Company had an amount of £82,592 owing from the director. During the year, the director made net repayments to the Company, resulting in the loan being fully settled before the year end. At 31 December 2025, the balance outstanding on the director's loan account was £nil.